Internal Medicine, Gastroenterology · Glendale, CA
NPI
1346429339
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
912 W Glenoaks Blvd
Glendale, CA, 91202
Phone (818) 507-0006
Groups this clinician bills Medicare through
Medicare paid, 2024
$365K
6,655 services
Medicare patients, 2024
993
Average age 73
Drug cost, 2024
$2.7M
6,460 prescriptions
Company payments, 2025
$319
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Armine Sarkisian was code 99214 (office e&m - established), 734 times for 473 patients. In total Armine Sarkisian billed 6,655 services in 28 codes, and Medicare paid $365K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 734 | 473 | $100.10 | $73K |
| 99204 Office E&M - New | Office | 486 | 486 | $126.67 | $62K |
| 43239 Upper GI Endoscopy | Facility | 342 | 333 | $74.06 | $25K |
| 99213 Office E&M - Established | Office | 323 | 188 | $71.10 | $23K |
| 99442 Telephone Services | Office | 311 | 299 | $71.06 | $22K |
| 45385 Colonoscopy - Lesion Removal | Facility | 223 | 220 | $182.49 | $41K |
| 46221 Digestive/Gastrointestinal | Office | 191 | 97 | $228.52 | $44K |
| 45380 Lower GI Endoscopy - Other | Facility | 151 | 150 | $51.02 | $7,704 |
| 46600 Digestive/Gastrointestinal | Office | 121 | 96 | $97.02 | $12K |
| 45378 Lower GI Endoscopy - Other | Facility | 109 | 105 | $125.62 | $14K |
| 83014 Clinical Chemistry | Office | 93 | 82 | $7.70 | $716 |
| 83013 Clinical Chemistry | Office | 93 | 82 | $66.01 | $6,139 |
| 99215 Office E&M - Established | Office | 72 | 70 | $140.28 | $10K |
| 99152 Anesthesia | Facility | 65 | 64 | $8.91 | $579 |
| 46614 Digestive/Gastrointestinal | Office | 26 | 21 | $126.92 | $3,300 |
By year: 2022 $436K for 5,183 services; 2023 $417K for 6,585 services; 2024 $365K for 6,655 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83013 Clinical Chemistry | 93 | 82 | $66.01 | $6,139 |
| 83014 Clinical Chemistry | 93 | 82 | $7.70 | $716 |
Medicare prescription drug claims, 2024
In 2024, the drug Armine Sarkisian prescribed most often to Medicare patients was Omeprazole-Sodium Bicarbonate (Omeprazole/Sodium Bicarbonate), with 930 prescriptions and refills. In total Armine Sarkisian wrote 6,460 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole-Sodium Bicarbonate Omeprazole/Sodium Bicarbonate | 930 | 970 | 183 | $684K |
| Linzess Linaclotide | 647 | 670 | 158 | $351K |
| Omeprazole Generic | 594 | 633 | 225 | $1,634 |
| Zenpep Lipase/Protease/Amylase | 405 | 421 | 118 | $669K |
| Pantoprazole Sodium Generic | 291 | 316 | 85 | $1,216 |
| Creon Lipase/Protease/Amylase | 262 | 274 | 52 | $467K |
| Sucralfate Generic | 258 | 268 | 73 | $3,744 |
| Hydrocortisone Generic | 233 | 241 | 90 | $3,242 |
| Dexlansoprazole Dr Dexlansoprazole | 205 | 211 | 53 | $35K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 196 | 196 | 191 | $12K |
| Procto-Med Hc Hydrocortisone | 189 | 198 | 86 | $2,660 |
| Suprep Sodium, Potassium,mag Sulfates | 177 | 177 | 176 | $19K |
| Levofloxacin Generic | 156 | 156 | 150 | $487 |
| Trulance Plecanatide | 147 | 148 | 45 | $81K |
| Amoxicillin Generic | 143 | 143 | 139 | $626 |
Brand drugs: - claims; generic drugs: 4,438 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Armine Sarkisian $319 ($319 in general payments such as food, travel and fees) from 4 companies. The largest payer was Janssen Biotech, Inc. with $240.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.